Global glioblastoma multiforme treatment market is expected to witness significant growth over the forecast period owing to high incidences of chronic oncology diseases. Rise in geriatric population which are at high risk of development of cancer and brain related disorders are expected to fuel the market growth. For More Information Visit - http://www.grandviewresearch.com/industry-analysis/glioblastoma-multiforme-treatment-gbm-market

1. Glioblastoma Multiforme Treatment (GBM) Market
Analysis By Therapy (Bevacozumab, Temozolomide, and
Carmustine), And Forecasts, 2015 to 2022
Global glioblastoma multiforme treatment market is expected to witness significant
growth over the forecast period owing to high incidences of chronic oncology
diseases. Rise in geriatric population which are at high risk of development of
cancer and brain related disorders are expected to fuel the market growth.
Absence of treatment therapies that can eradicate malignant growth of tumor from
nerve cells is also anticipated to boost R&D in this market and thereby
subsequently propel growth in the coming seven years. Glioma cells resist
conventional anti cancer treatments and thus there is a rising need for development
of alkylating drugs and therapies in this sector which is further expected to
augment market growth.
For More Information on "Glioblastoma Multiforme Treatment (GBM)
Market Research Reports" visit -
http://www.grandviewresearch.com/industry-analysis/glioblastoma-
multiforme-treatment-gbm-market

2. Furthermore, R&D in cell therapy, molecular biotechnology and gene therapy to
develop personalized and regenerative medicine to cure brain related cancer
diseases and curb the disease incidence rate is expected to produce a positive
impact on market growth. Rising technological advancements in biotechnology
such as use of new transfection vectors in order to achieve higher bioavailability
and therapeutic efficacy are also expected to drive market.
Presence of drugs in clinical phases of development for treatment of glioblastoma
multiforme with lesser occurrence of adverse events as compared to available drug
options are expected to drive market growth in coming seven years. Other factors
that are expected to attribute towards further advancement include genomics based
research for discovery of novel targets and development of novel moieties that can
act on these targets.

3. Geographical analysis of this market segregates it into North America, Asia-
Pacific, Europe, Latin America and MEA. North America accounted for the largest
market share with respect to revenue in 2014. Factors attributing towards this large
include development of biopharmaceuticals by using advanced biotechnology
techniques. Presence of regulatory bodies in this region that create awareness for
the available treatment options are also responsible for high market share of this
region. Moreover, there are number of vaccine products under clinical phase of
development in this region owing to presence of government and non-government
support for research.
Developing economies such as India and China in Asia Pacific region are
anticipated to exhibit significant growth throughout the forecast period owing to
improvements in health care infrastructure of this region coupled with rising
awareness amongst population in this region.

4. Major players operating in this market include Sun Pharmaceutical Industries, Ltd.,
Teva Pharmaceutical Industries, Ltd., Arbor Pharmaceuticals LLC., Merck & Co.,
Inc., and F. Hoffmann-Le Roche AG. These players are involved in adoption of
competitive strategies such as mergers with small entities operating in market and
research laboratories in order to maintain market share.
Request TOC of “Glioblastoma Multiforme Treatment (GBM) Market
Research Reports" visit - http://www.grandviewresearch.com/industry-
analysis/glioblastoma-multiforme-treatment-gbm-market/request-toc
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports,
and consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals, materials,
healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Website: Grand View Research
Blog Site: http://www.divog.org/